Abdelnabi Mahmoud, Eshak Nouran, Saleh Yehia, Almaghraby Abdallah
Cardiology and Angiology Unit, Department of Clinical and Experimental Internal Medicine, Medical Research Institute, Alexandria University Alexandria, Egypt.
Rheumatology Unit, Department of Internal Medicine, Faculty of Medicine, Alexandria University Alexandria, Egypt.
Eur Cardiol. 2020 Jun 17;15:e51. doi: 10.15420/ecr.2020.16. eCollection 2020 Feb.
The world is dealing with a global pandemic of severe acute respiratory coronavirus 2 (SARS-CoV-2). Coronavirus disease 2019 (COVID-19), which is the illness caused by SARS-CoV-2, is overwhelming healthcare systems around the world. Although the main clinical manifestations of COVID-19 are respiratory symptoms, several reports have noted myocarditis, cardiomyopathy, arrhythmias and cardiac arrests as COVID-19 complications. Here, the authors highlight the current understanding of the pathophysiology of myocarditis related to COVID-19 and its management.
全球正在应对由严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引发的全球大流行。2019冠状病毒病(COVID-19)是由SARS-CoV-2引起的疾病,正在使世界各地的医疗系统不堪重负。尽管COVID-19的主要临床表现为呼吸道症状,但已有多篇报告指出,心肌炎、心肌病、心律失常和心脏骤停是COVID-19的并发症。在此,作者着重介绍了目前对与COVID-19相关的心肌炎病理生理学及其治疗的认识。